📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. (2013)

First Author: Feig C

Attributed to: Confidence in Concept 2012 - Cambridge funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1320318110

PubMed Identifier: 24277834

Publication URI: http://europepmc.org/abstract/MED/24277834

Type: Journal Article/Review

Volume: 110

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 50

ISSN: 0027-8424